Chemistry Reference
In-Depth Information
Ohta A, Uehara M, Sakai K, Takasaki M, Adlercreutz H, Morohashi T, and Ishimi Y (2002)
A combination of dietary fructooligosaccharides and isoflavone conjugates increases
femoral bone mineral density and equol production in ovariectomized mice.
J Nutr
132,
2048-2054.
Paineau D, Payen F, Panserieu S, Coulombier G, Sobaszek A, Lartigau I, Brabet M, Galmiche
JP, Tripodi D, Sacher-Huvelin S, Chapalain V, Zourabichvili O, Respondek F, Wagner
A, and Bornet FR (2008) The effects of regular consumption of short-chain fructo-oli-
gosaccharides on digestive comfort of subjects with minor functional bowel disorders.
Br J Nutr
99, 311-318.
Pajari A, Rajakangas J, Päivärinta E, Kosma V, Rafter J, and Mutanen M (2003) Promotion
of intestinal tumor formation by inulin is associated with an accumulation of cytosolic
beta-catenin in Min mice.
Int J Cancer
106, 653-660.
Passeron T, Lacour J, Fontas E, and Ortonne J (2006) Prebiotics and synbiotics: Two promis-
ing approaches for the treatment of atopic dermatitis in children above 2 years.
Allergy
61, 431-437.
Perrin P, Pierre F, Patry Y, Champ M, and Berreur M (2001) Only fibres promoting a stable butyrate
producing colonic ecosystem decrease the rate of aberrant crypt foci in rats.
Gut
48, 53-61.
Picard C, Fioramonti J, Francois A, Robinson T, Neant F, and Matuchansky C (2005) Review
article: Bifidobacteria as probiotic agents—Physiological effects and clinical benefits.
Aliment Pharmacol Ther
22, 495-512.
Pierre F, Perrin P, Bassonga E, Bornet F, and Meflah K (1999) T cell status influences colon
tumor occurrence in min mice fed short-chain fructo-oligosaccharides as a diet supple-
ment.
Carcinogenesis
20, 1953-1956.
Pool-Zobel B (2005) Inulin-type fructans and reduction in colon cancer risk: Review of exper-
imental and human data.
Br J Nutr
93, S73-90.
Pool-Zobel B, Van Loo J, Rowland I, and Roberfroid M (2002) Experimental evidences on
the potential of prebiotic fructans to reduce the risk of colon cancer.
Br J Nutr
87,
S273-S281.
Rafter J (2002) Scientific basis of biomarkers and benefits of functional foods for reduction of
disease risk: Cancer.
Br J Nutr
88, S219-S224.
Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M,
O'Sullivan GC, Pool-Zobel B, Rechkemmer G, Roller M, Rowland I, Salvadori M, Thijs
H, Van Loo J, Watzl B, and Collins JK (2007) Dietary synbiotics reduce cancer risk fac-
tors in polypectomized and colon cancer patients.
Am J Clin Nutr
85, 488-496.
Reddy S, Sanders TA, Owen RW, and Thompson MH (1998) Faecal pH, bile acid and sterol
concentrations in premenopausal Indian and white vegetarians compared with white
omnivores.
Br J Nutr
79, 495-500.
Rémésy C, Lopez H, Levrat-Verny M, Demigné C, and Rayssiguier Y (2002) Influence des
produits végétaux et de divers glucides fermentescibles sur la biodisponibilité des
minéraux. In
Aliments Fonctionnels,
Roberfroid M. (coordonnateur), pp. 73-84 [TD
Lavoisier, editor].
Roller M, Clune Y, Collins K, Rechkemmer G, and Watzl B (2007) Consumption of prebi-
otic inulin enriched with oligofructose in combination with the probiotics
Lactobacillus
rhamnosus
and
Bifidobacterium lactis
has minor effects on selected immune parameters
in polypectomised and colon cancer patients.
Br J Nutr
97, 676-684.
Salminen S, Bouley C, Boutron-Ruault M, Cummings J, Franck A, Gibson G, Isolauri E,
Moreau M, Roberfroid M, and Rowland I (1998) Functional food science and gastroin-
testinal physiology and function.
Br J Nutr
80, S147-171.
